scholarly article | Q13442814 |
P356 | DOI | 10.2337/DIAB.23.3.199 |
P953 | full work available at URL | https://diabetesjournals.org/diabetes/article-pdf/23/3/199/347754/23-3-199.pdf |
https://journals.org/diabetes/diabetes/article-pdf/23/3/199/347754/23-3-199.pdf | ||
P698 | PubMed publication ID | 4816891 |
P2093 | author name string | W. G. Blackard | |
N. C. Nelson | |||
S. S. Andrews | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | glucagon | Q28163629 |
internal medicine | Q11180 | ||
P1104 | number of pages | 4 | |
P304 | page(s) | 199-202 | |
P577 | publication date | 1974-03-01 | |
P1433 | published in | Diabetes | Q895262 |
P1476 | title | Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions | |
Portal and Peripheral Vein Immunoreactive Glucagon Concentrations After Arginine or Glucose Infusions | |||
P478 | volume | 23 |
Q92186150 | AAV GCG-EGFP, a new tool to identify glucagon-secreting α-cells |
Q51521523 | Acute effects of distal pancreatectomy on portal and peripheral blood insulin concentrations in patients undergoing total gastrectomy. |
Q35903867 | Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects |
Q70492114 | Combined hormonal infusion simulates the metabolic response to injury |
Q69033698 | Comparison of the effects of intravenous and intrasplenic infusions of glucagon on cardiac output and its distribution in the rat |
Q35034818 | Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp |
Q70782782 | Effect of counterregulatory hormones on kinetic response to ingested glucose in dogs |
Q69618094 | Effect of glucagon on alcohol dehydrogenase activity in rat hepatocyte culture |
Q36988493 | Effect of somatostatin-induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet |
Q50176247 | Effect of stimulation of endogenous glucagon secretion by amino acid administration on canine hepatic bile flow |
Q45714790 | Effect of total hepatectomy on coagulation and glucose homeostasis in the pig |
Q37355181 | Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance |
Q35199534 | Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin |
Q54397927 | Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes. |
Q37357010 | Evidence for a catabolic role of glucagon during an amino acid load |
Q72258285 | Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM |
Q51653935 | Gastrointestinal/pancreatic hormone concentrations in the portal venous system of nine patients with organic hyperinsulinism |
Q51675091 | Glucagon control of fasting glucose in man. |
Q35197978 | Glucagon response to hypoglycemia in sympathectomized man |
Q39852777 | Glucagon-New Concepts About an “Old” Hormone |
Q39821195 | Glucagon: Secretion and Actions |
Q42454541 | Glucose regulation of glucagon secretion independent of B cell activity |
Q72893434 | Hormone-induced effects on the rat liver microsomal glucose-6-phosphatase system in vitro |
Q51658275 | Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage. |
Q72438623 | Hyperglucagonemia after removal of lower bowel in rats |
Q58829831 | Impaired insulin secretion in human diabetes mellitus. I. The effect of alpha-adrenergic inhibition |
Q34202344 | Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study |
Q70362213 | Improved but not normalized glucose counter-regulation during glucagon infusion in Type 1 (insulin-dependent) diabetes |
Q35198870 | Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon |
Q41624817 | Interaction of secretin and glucagon on exocrine pancreatic secretion |
Q35003271 | Kinetics of glucagon in man: effects of starvation |
Q72474472 | Lack of effect of somatostatin on the glucagon-induced alterations of hepatic metabolism of [1-14C]oleate |
Q67049700 | Modulation of the catabolic activity of glucagon by endogenous insulin secretion in obese man |
Q51614258 | Plasma concentrations of glucagon during hyperglycemic clamp with or without somatostatin infusion in obese subjects. |
Q72884516 | Rapid rise in plasma glucagon induced by acute cold exposure in man and rat |
Q42819970 | Regulation of the activity and synthesis of malic enzyme in 3T3-L1 cells |
Q37039189 | Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia |
Q70250656 | Role of glucose and insulin in the dynamic regulation of glucagon release by the perfused rat pancreas |
Q40381479 | Signals for Glucagon Secretion |
Q89473788 | The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition |
Q72856028 | The effect of streptozotocin-induced diabetes on the early steps of glucagon action in isolated rat liver cells |
Q44798559 | The effects of intraportl infusions of glucagon on the hepatic arterial and portal venous vascular beds of the dog: Inhibition of hepatic arterial vasoconstrictor responses to noradrenaline |
Q44754905 | The metabolic response to norepinephrine in normal versus diabetic man. |
Q39798407 | The role of glucagon in the regulation of plasma lipids |
Q37046188 | The role of the liver in glucagon metabolism |
Search more.